F Prevot1, L Rebibo, C Cosse, F Browet, C Sabbagh, J-M Regimbeau. 1. Department of Digestive and Metabolic Surgery, North Hospital, Amiens University Medical Center, Place Victor Pauchet, F-80054, Amiens, Cedex 1, France.
Abstract
INTRODUCTION: During cholecystectomy, intraoperative cholangiography using contrast fluid (IOC-CF) is still the "gold standard" for biliary tract identification but has many associated pitfalls. A new IOC technique using indocyanine green (IOC-IG) appears to be promising. Here, we studied the effectiveness of IOC-IG (vs IOC-CF) during day-case laparoscopic cholecystectomy. MATERIALS AND METHODS: Over a 6-month period, we included 23 patients (with no cirrhosis or risk factors for choledocholithiasis) scheduled for day-case laparoscopic cholecystectomy. The primary efficacy criterion was the "analyzability rate" (i.e., the ability to identify the cystic duct, the cystic duct-hepatic duct junction, and the common bile duct) for the IOC-CF and IOC-IG procedures after dissection. Indocyanine green was infused under general anesthesia. The same near-infrared laparoscopic imaging system was used for IOC-IG and conventional visual inspection. IOC-CF was always attempted after dissection. Each patient served as his/her own control. Cholecystectomies were video-recorded for subsequent off-line, blind analysis. RESULTS: The analyzability rate was 74 % for IOC-IG after dissection, 70 % for IOC-CF (p = 0.03), 26 % for conventional visual inspection, and 48 % for IOC-IG before dissection. When each IOC modality (conventional visual inspection, IOC-IG before and after dissection) was considered as a diagnostic test, the accuracy for simultaneous identification of the three anatomic elements was respectively 48, 52, and 74 %. No adverse events occurred during the IOC-IG procedure. CONCLUSION: IOC-IG was feasible and safe. Our results suggest that this technique is more effective than IOC-CF for biliary tract identification after dissection and may constitute a powerful diagnostic test for the detection of extrahepatic ducts.
INTRODUCTION: During cholecystectomy, intraoperative cholangiography using contrast fluid (IOC-CF) is still the "gold standard" for biliary tract identification but has many associated pitfalls. A new IOC technique using indocyanine green (IOC-IG) appears to be promising. Here, we studied the effectiveness of IOC-IG (vs IOC-CF) during day-case laparoscopic cholecystectomy. MATERIALS AND METHODS: Over a 6-month period, we included 23 patients (with no cirrhosis or risk factors for choledocholithiasis) scheduled for day-case laparoscopic cholecystectomy. The primary efficacy criterion was the "analyzability rate" (i.e., the ability to identify the cystic duct, the cystic duct-hepatic duct junction, and the common bile duct) for the IOC-CF and IOC-IG procedures after dissection. Indocyanine green was infused under general anesthesia. The same near-infrared laparoscopic imaging system was used for IOC-IG and conventional visual inspection. IOC-CF was always attempted after dissection. Each patient served as his/her own control. Cholecystectomies were video-recorded for subsequent off-line, blind analysis. RESULTS: The analyzability rate was 74 % for IOC-IG after dissection, 70 % for IOC-CF (p = 0.03), 26 % for conventional visual inspection, and 48 % for IOC-IG before dissection. When each IOC modality (conventional visual inspection, IOC-IG before and after dissection) was considered as a diagnostic test, the accuracy for simultaneous identification of the three anatomic elements was respectively 48, 52, and 74 %. No adverse events occurred during the IOC-IG procedure. CONCLUSION: IOC-IG was feasible and safe. Our results suggest that this technique is more effective than IOC-CF for biliary tract identification after dissection and may constitute a powerful diagnostic test for the detection of extrahepatic ducts.
Authors: Nader N Massarweh; Allison Devlin; Jo Ann Broeckel Elrod; Rebecca Gaston Symons; David R Flum Journal: J Am Coll Surg Date: 2008-10-02 Impact factor: 6.113
Authors: Rutger M Schols; Nicole D Bouvy; Ad A M Masclee; Ronald M van Dam; Cornelis H C Dejong; Laurents P S Stassen Journal: Surg Endosc Date: 2012-10-18 Impact factor: 4.584
Authors: K T Buddingh; A N Morks; H O ten Cate Hoedemaker; C B Blaauw; G M van Dam; R J Ploeg; H S Hofker; V B Nieuwenhuijs Journal: Surg Endosc Date: 2011-07-27 Impact factor: 4.584
Authors: Hector Silva-Baez; Pedro Coello-Ramírez; Eddy Mizraím Ixtabalán-Escalante; Eduardo Sotelo-Anaya; Mariana Gallo-Morales; Eduardo Cordero-Estrada; Victor Hugo Sainz-Escarrega; César Felipe Ploneda-Valencia Journal: Ann Med Surg (Lond) Date: 2015-12-21
Authors: S L Vlek; D A van Dam; S M Rubinstein; E S M de Lange-de Klerk; L J Schoonmade; J B Tuynman; W J H J Meijerink; M Ankersmit Journal: Surg Endosc Date: 2016-11-14 Impact factor: 4.584
Authors: Leonora S F Boogerd; Henricus J M Handgraaf; Volkert A L Huurman; Hwai-Ding Lam; J Sven D Mieog; Wendeline J van der Made; Cornelis J H van de Velde; Alexander L Vahrmeijer Journal: Surg Innov Date: 2017-04-29 Impact factor: 2.058
Authors: Marjolein Ankersmit; Dieuwertje A van Dam; Anne-Sophie van Rijswijk; Baukje van den Heuvel; Jurriaan B Tuynman; Wilhelmus J H J Meijerink Journal: Surg Innov Date: 2017-02-08 Impact factor: 2.058
Authors: Labrinus van Manen; Henricus J M Handgraaf; Michele Diana; Jouke Dijkstra; Takeaki Ishizawa; Alexander L Vahrmeijer; Jan Sven David Mieog Journal: J Surg Oncol Date: 2018-06-24 Impact factor: 3.454